Publication | Open Access

Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

SclerostinBone Morphogenic ProteinMalignant MesotheliomaMegakaryocyte Potentiating FactorPathologyOsteocalcinMedicineRadiation OncologyMesothelin ProteinsTumor MicroenvironmentCancer Research